Steven A. Hofstadler

Ionis Pharmaceuticals (United States)

Papers

1

Total Citations

80

H-Index

1

About

Steven A. Hofstadler is a leading figure in bioanalytical chemistry and mass spectrometry, renowned for pioneering high-throughput methods that bridge molecular biology and analytical instrumentation. His primary research focuses on the development of automated sample preparation techniques for nucleic acid analysis, with a major contribution being the creation of a highly efficient, automated system for purifying and desalting PCR products prior to electrospray ionization mass spectrometry (ESI-MS). This work, detailed in his highly cited 2003 paper (80 citations), revolutionized the speed and reliability of genotyping and pathogen detection by eliminating manual, error-prone steps. Hofstadler’s innovations have had a profound impact on clinical diagnostics and biodefense, enabling rapid, accurate identification of microorganisms from complex samples. His achievements include advancing the integration of liquid handling robotics with mass spectrometric analysis, setting new standards for sensitivity and throughput. For students and researchers, Hofstadler’s work exemplifies how clever automation can transform fundamental analytical challenges into robust, scalable solutions, making him a key influencer in the field of mass spectrometry-based bioanalysis.

Research Focus

Key Achievements

1
H-Index
1
Papers
80
Total Citations
80
Avg Citations/Paper
🏆 Most Cited Paper
A highly efficient and automated method of purifying and desalting PCR products for analysis by electrospray ionization mass spectrometry
80 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Ionis Pharmaceuticals (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago